Be a PRO & get up to 50% off on select brands. Explore Now
you are here: HomeNewsTrendsHealth

Delhi receives over 60,000 Covaxin doses for 45-plus, key workers: AAP MLA Atishi

Still, the city has only two days of Covaxin stock left for this category, while Covishield doses for the group can last up to four days, Atishi said. She also said that 1.13 lakh beneficiaries received jabs on May 17. Around 10.75 lakh people have got both the doses since the inoculation drive began on January 16.

May 18, 2021 / 07:18 PM IST

Delhi on Tuesday received over 60,000 Covaxin doses for key workers and those aged above 45, AAP MLA Atishi said.

Still, the city has only two days of Covaxin stock left for this category, while Covishield doses for the group can last up to four days, she said.

Also Read: COVID-19 | Initiatives announced by state govts for children who lost both parents to pandemic

She also said that 1.13 lakh beneficiaries received jabs on May 17.

Around 10.75 lakh people have got both the doses since the inoculation drive began on January 16.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

"After Tuesday evening, the city will have only three days of Covishield stock left for the 18-44 age group. We appeal to the central government to make more vaccines available for this category immediately,” she said, adding the city government might have to stop vaccination for them from next week.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: May 18, 2021 07:18 pm

stay updated

Get Daily News on your Browser
Sections